SALLY BAIRD: Open Payments
NPI 1710153515 · HUDSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 35 payments from 13 companies in 2025. Trend: 2023 $819 · 2024 $621 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $171 |
| GlaxoSmithKline, LLC. | 5 | $115 |
| PFIZER INC. | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Abbott Laboratories | 2 | $46 |
| Novo Nordisk Inc | 2 | $34 |
| Verona Pharma, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: TRELEGY ELLIPTA, VRAYLAR, UBRELVY, FREESTYLE LIBRE 3, NURTEC ODT, AIRSUPRA, QULIPTA, ELIQUIS.
Industry payments across NC — which companies pay providers there.
